Apogee Therapeutics, Inc.
APGE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$65,021 | -$66,096 | -$55,339 | -$67,218 |
| Dep. & Amort. | $406 | $399 | $207 | $76 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $11,877 | $11,344 | $11,126 | $7,609 |
| Change in WC | -$837 | -$6,837 | -$2,949 | -$5,956 |
| Other Non-Cash | -$680 | -$839 | -$1,522 | -$2,225 |
| Operating Cash Flow | -$54,255 | -$62,029 | -$48,477 | -$67,714 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$768 | -$4,317 | $1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$107,632 | -$47,379 | -$98,201 | -$60,584 |
| Inv. Sales/Matur. | $125,577 | $126,272 | $115,500 | $106,950 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $17,945 | $78,125 | $12,982 | $46,367 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $19,738 | $1,180 | $622 | $44,356 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $19,738 | $1,180 | $622 | $44,356 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$16,572 | $17,276 | -$34,873 | $23,009 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $124,486 | $107,210 | $142,083 | $119,074 |
| End Cash | $107,914 | $124,486 | $107,210 | $142,083 |
| Free Cash Flow | -$54,255 | -$62,797 | -$52,794 | -$67,713 |